Gisele Dion
Director/Board Member at INHIBIKASE THERAPEUTICS, INC.
Net worth: 28 150 $ as of 2024-05-30
Profile
Ms. Gisele Dion is on the Board of Directors at Inhibikase Therapeutics, Inc. Ms. Dion was previously employed as an Independent Director by Cytek Biosciences, Inc., a Chief Accounting Officer, Senior VP & Controller by Takeda Pharmaceutical Co., Ltd., a Chief Accounting Officer by Shire Plc, a Chief Accounting Officer, Senior VP & Controller by Shire Pharmaceuticals LLC, and a Senior Director-Technical Accounting & Controller by Biogen, Inc. She received her undergraduate degree from Fairfield University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CYTEK BIOSCIENCES, INC.
0.00% | 2024-03-30 | 5,000 ( 0.00% ) | 28 150 $ | 2024-05-30 |
| 2024-04-14 | 0 ( -.--% ) | - $ | 2024-05-30 |
Gisele Dion active positions
| Companies | Position | Start |
|---|---|---|
| INHIBIKASE THERAPEUTICS, INC. | Director/Board Member | 2022-08-31 |
Former positions of Gisele Dion
| Companies | Position | End |
|---|---|---|
| CYTEK BIOSCIENCES, INC. | Director/Board Member | 2024-06-04 |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Comptroller/Controller/Auditor | 2021-02-28 |
| SHIRE | Comptroller/Controller/Auditor | 2018-12-31 |
Shire Pharmaceuticals LLC
 Shire Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Pharmaceuticals LLC is an American company that manufactures pharmaceutical products. | Comptroller/Controller/Auditor | 2018-12-31 |
| BIOGEN INC. | Comptroller/Controller/Auditor | 2015-12-31 |
Training of Gisele Dion
| Fairfield University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| CYTEK BIOSCIENCES, INC. | Health Technology |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
| BIOGEN INC. | Health Technology |
| INHIBIKASE THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
Shire Pharmaceuticals LLC
Shire Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Pharmaceuticals LLC is an American company that manufactures pharmaceutical products. | Health Technology |
- Stock Market
- Insiders
- Gisele Dion
